Researchers have designed a new, more powerful mRNA that enhanced immune responses to the SARS-CoV-2 mRNA vaccine when used as an adjuvant. In this lymph node, the researchers observed increased B-cell activity in germinal centers (hotspots of antibody production) and...
The World Health Organization (WHO) has declared a global public health emergency as the mpox virus ravages the African continent with cases having spiked by 160% this year. As Bavarian Nordic ramps up production of the only marketed mpox vaccine, a few clinical...
CHENGDU, China, Aug. 8, 2024 /PRNewswire/ — WestGene Biopharma is proud to announce that its mRNA therapeutic cancer vaccine, WGc-043, has received dual IND approvals from China’s National Medical Products Administration (NMPA) and the US FDA. This...
Besides vaccines, mRNA technology is being explored for therapeutic applications in oncology, infectious diseases, genetic disorders, and other areas. This diversification expands the market potential. The mRNA vaccines and therapeutics market was projected to attain...
On July 8th, Moderna, Inc. and Mitsubishi Tanabe Pharma Corporation (MTPC) officially entered into a joint agreement to co-promote Moderna’s mRNA respiratory vaccine portfolio in Japan, alongside Moderna’s COVID-19 vaccine, Spikevax. Moderna’s Success Sparks...
